This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting neurological and psychiatric disorders, such as antidepressants and anxiolytics. Its trifluoro and methoxy groups enhance its binding affinity to specific receptors in the brain, making it valuable for designing drugs with improved efficacy and selectivity. Additionally, it is used in preclinical studies to explore its potential therapeutic effects and pharmacokinetic properties.